BPGbio, Inc.

📍 Waltham, United States🗓 Founded 2006👥 74 employees💰 Last funded Jan 2023
Biotechnology Research🌐 BPGbio.com
Website LinkedIn
BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BPGbio, Inc.?
BPGbio, Inc. has 1 investors on record on gritt.io.
When did BPGbio, Inc. last raise funding?
The most recent investment in BPGbio, Inc. recorded on gritt.io was in January 2023.
When was BPGbio, Inc. founded?
BPGbio, Inc. was founded in 2006.
What industry is BPGbio, Inc. in?
BPGbio, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BPGbio, Inc. based?
BPGbio, Inc. is headquartered in Waltham, United States.